Understanding the potential of recombinant PTEN in cancer therapeutics

Show simple item record

dc.contributor.author Arora, Neha
dc.date.accessioned 2019-07-10T06:04:51Z
dc.date.available 2019-07-10T06:04:51Z
dc.date.issued 2018
dc.identifier.other ROLL NO.136106013
dc.identifier.uri http://gyan.iitg.ernet.in/handle/123456789/1101
dc.description Supervisor: Siddhartha Sankar Ghosh en_US
dc.description.abstract The most dynamic and diverse class of macromolecules, proteins come armed with an array of opportunities in the field of therapeutics. Their delicate and complex structure is essential to perform multifaceted functions. However, their structure is prone to degradation, which posses a major challenge in harnessing their therapeutic remuneration. Amid numerous formulations, maneuvering nanomaterials provide ample scope for judicious designing of application based nanostructures.Given the importance of a curative protein in the field of healthcare, the current thesis work focuses on characterizing and evaluating the anti-proliferative efficacy of the two isoforms, PTEN and PTEN-Long, alone and in combination with anti-cancer drugs. The introduction section describes in details the role of aberrant signaling in cancer and the panorama of recombinant protein therapy, which is consolidated by presenting literature reports on the subject in the literature review section. The material and methods section describes in details the materials required and the methodologies of the experimental procedures. The results and discussion section begins with the cloning and purification of PTEN and its transcriptional variant PTEN-Long. The cell based studies establishes the anti-proliferative and anti-invasive role of the membrane-permeable recombinant PTEN-Long protein in primary glioblastoma cell line. To investigate the therapeutic benefit of PTEN, silica nanoparticles were successfully employed to mediate stabilization of the GST tagged PTEN protein. Silica nanoparticles mediated cellular delivery resulted in reduced proliferation of drug resistant glioblastoma en_US
dc.language.iso en en_US
dc.relation.ispartofseries TH-1979;
dc.title Understanding the potential of recombinant PTEN in cancer therapeutics en_US
dc.type Thesis en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record



My Account